Highlights Review: Dialogue on Beta-Blockers in Coronary Heart Disease - The Thrid of the 2026 Asian Cardiovascular Disease Series of Web Seminars

The third of the 2026 Asian Cardiovascular Disease Series of Web Seminars was successfully held on April 15, 2026, bringing together a distinguished panel of experts from China and Europe for an in-depth dialogue on the evolving role of beta-blockers in coronary heart disease management.

The webinar was chaired by Prof. Jian Liu (CN), who opened the session with welcoming remarks and set the stage for a dynamic academic exchange. The program featured two keynote presentations that highlighted both the latest clinical evidence and practical therapeutic strategies. Prof. Ricardo Fontes-Carvalho (PT) delivered an insightful lecture titled "Coronary Heart Disease and Beta-Blockers: Update on Latest Evidence," while Prof. Wei Liu (CN) followed with a comprehensive overview of "The Role of Beta-Blockers in the Latest Treatment Strategies for Coronary Heart Disease."

A dedicated discussion segment enriched the dialogue, featuring valuable perspectives from Prof. Wenduo Zhang (CN) and Prof. Jianqiang Li (CN). The interactive exchange fostered a deeper understanding of how beta-blocker therapy continues to shape contemporary cardiovascular care.

This event concluded with a summary delivered by Prof. Jian Liu, who encapsulated the key takeaways from this cross-border collaboration and emphasized the importance of ongoing international dialogue in advancing patient outcomes.

Welcoming you to the next installment of the 2026 Asian Cardiovascular Disease Webinar Series.